Increased Risk of Stroke in Patients With Fibromyalgia: A Population-BASED Cohort Study

Chun-Hung Tseng1, Jiunn-Horng Chen, Yu-Chiao Wang

  • 1From the Department of Neurology, China Medical University Hospital (C-HT); Graduate Institute of Clinical Medical Science and School of Medicine, College of Medicine, China Medical University (C-HT, J-HC, C-HK); Department of Internal Medicine (J-HC); Management Office for Health Data (Y-CW); College of Medicine, China Medical University, Taichung (Y-CW); Department of Nuclear Medicine, E-Da Hospital, I-Shou University, Kaohsiung (M-CL); Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan (C-HK).

Medicine
|March 4, 2016
PubMed
Summary

Fibromyalgia (FM) significantly increases stroke risk, even without other health conditions. This research highlights FM as a key risk factor, especially for younger individuals, emphasizing the need for proactive stroke prevention in FM patients.

Related Concept Videos

Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
560
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
576
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
450